Releaf

Let’s rethink healthcare 🍃🤍 The UK’s fastest-growing plant-based care clinic.

[Releaf @releaf_uk]

Talk to a medical cannabis specialist for £9.99, our lowest ever price, for a limited time.

If you've been meaning to get your symptoms looked at, this is the moment. You'll speak to a GMC-registered specialist, and it's fully refundable if you're not eligible.

Check your eligibility: https://t.co/nAYyiTN8gh

Ends 11:59pm, 7 Aug. UK, 18+.

[Releaf @releaf_uk]

Medical cannabis has been legal in the UK since 2018. Seven years on - do you think public perception has caught up with the science? 🧑‍⚕️🌿

[Releaf @releaf_uk]

Endometriosis affects 1 in 10 women. Why do you think it still takes nearly a decade to diagnose? 🎗️

[Releaf @releaf_uk]

Meet Matt - a Releaf patient since September 2024, managing Tourette's syndrome, arthritis, and anxiety.

Diagnosed with Tourette's in his 40s during COVID, Matt describes it as a shock to the system. The social anxiety that followed had a real impact on his work, his confidence, and the hobbies he loved. Since beginning his medical cannabis treatment plan with Releaf, Matt has found a new sense of consistency - and the confidence to get back out into the world.

Read Matt's full story here 👇

https://t.co/3nZDYfFKS7

[Releaf @releaf_uk]

@NORML Policy changes like this can have a real impact on access. When clinicians have more discretion, it can open up conversations and options for patients who may not have been considered before ⚖️

[Releaf @releaf_uk]

@marclanders This is where the impact becomes very real - especially in conditions like severe epilepsy. Reductions in seizure frequency, alongside improvements in sleep and quality of life, can make a huge difference not just for patients but for families as well 💛

[Releaf @releaf_uk]

@marclanders This is where nuance really matters. Conversations around cannabis and mental health are often simplified, but the reality is much more complex - especially when it comes to individual risk factors and context 🧠

[Releaf @releaf_uk]

@SeedBankME Early-stage research like this is always interesting to follow, especially around inflammation-related conditions. It’s still a long way from translation into human outcomes, but it shows how wide the scope of cannabinoid research is becoming 🔬

[Releaf @releaf_uk]

@CarverJohns As more attention shifts beyond THC and CBD, it really shows how complex cannabis is as a treatment option. Compounds like CBG and CBC could play a role in more targeted, personalised approaches as the research continues to evolve.

[Releaf @releaf_uk]

@CarverJohns Crohn’s can be incredibly difficult to manage day-to-day, so any improvement in symptoms or remission rates is significant for patients. It highlights how important it is to keep exploring different approaches that can support quality of life alongside traditional care.

[Releaf @releaf_uk]

@CarverJohns Endometriosis is often about managing ongoing, difficult-to-treat pain - so it’s not surprising to see patients exploring different options. When quality of life improves, even in small ways, it can make a real difference to how people get through their day 🌿

[Releaf @releaf_uk]

@iambillyuk This highlights how the environment around cannabis use - regulation, quality control, and access - can influence outcomes just as much as the substance itself. Moving people away from the illicit market can change the whole context of use 🌿

[Releaf @releaf_uk]

@CarverJohns Sleep tends to be one of the first areas patients report improvements in. When people start sleeping better, it often has a knock-on effect on mood, pain, and overall wellbeing - which is why sleep support comes up so often in medical cannabis care 🌙

[Releaf @releaf_uk]

@marclanders Really interesting area of research. The relationship between cannabinoids and brain ageing is still being explored, but findings like this show why the neurological effects of cannabis are getting more attention in scientific discussions 🧠🌿

[Releaf @releaf_uk]

@marclanders Stories like this come up often in patient conversations. For some people, medical cannabis becomes part of reducing or moving away from other medications, especially in long-term pain management. It’s a reminder of how individual treatment journeys can be 🌿

[Releaf @releaf_uk]

@weedmaps Good example of how important large-scale data is in shaping the conversation. As more long-term research emerges, it helps move discussions about cannabis and cognitive health away from assumptions and toward evidence 📊

[Releaf @releaf_uk]

@NORML Interesting to see more research exploring this area. As larger and longer-term studies emerge, they help bring more clarity to the conversation around cannabis, cognition, and ageing 🧠

[Releaf @releaf_uk]

Anxiety and distress can become a huge part of a cancer journey, yet they’re often the hardest symptoms to address. In our experience, many patients seek support for anxiety and sleep alongside their primary condition - it shows how important whole-person care is in treatment conversations 💭

[Releaf @releaf_uk]

Legal since 2018 and the awareness is only just catching up🌿

#letsrethinkhealthcare #patientcare #plantbasedmedicines #wellbeing